Literature DB >> 25653426

Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination.

Anika Reuter1, Scott E Panozza2, Christophe Macri2, Claire Dumont2, Jessica Li3, Haiyin Liu4, Elodie Segura5, Javier Vega-Ramos6, Nishma Gupta7, Irina Caminschi8, Jose A Villadangos9, Angus P R Johnston10, Justine D Mintern11.   

Abstract

Ab-targeted vaccination involves targeting a receptor of choice expressed by dendritic cells (DCs) with Ag-coupled Abs. Currently, there is little consensus as to which criteria determine receptor selection to ensure superior Ag presentation and immunity. In this study, we investigated parameters of DC receptor internalization and determined how they impact Ag presentation outcomes. First, using mixed bone marrow chimeras, we established that Ag-targeted, but not nontargeted, DCs are responsible for Ag presentation in settings of Ab-targeted vaccination in vivo. Next, we analyzed parameters of DEC205 (CD205), Clec9A, CD11c, CD11b, and CD40 endocytosis and obtained quantitative measurements of internalization speed, surface turnover, and delivered Ag load. Exploiting these parameters in MHC class I (MHC I) and MHC class II (MHC II) Ag presentation assays, we showed that receptor expression level, proportion of surface turnover, or speed of receptor internalization did not impact MHC I or MHC II Ag presentation efficiency. Furthermore, the Ag load delivered to DCs did not correlate with the efficiency of MHC I or MHC II Ag presentation. In contrast, targeting Ag to CD8(+) or CD8(-) DCs enhanced MHC I or MHC II Ag presentation, respectively. Therefore, receptor expression levels, speed of internalization, and/or the amount of Ag delivered can be excluded as major determinants that dictate Ag presentation efficiency in setting of Ab-targeted vaccination.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25653426     DOI: 10.4049/jimmunol.1402535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1.

Authors:  Hamish E G McWilliam; Sidonia B G Eckle; Alex Theodossis; Ligong Liu; Zhenjun Chen; Jacinta M Wubben; David P Fairlie; Richard A Strugnell; Justine D Mintern; James McCluskey; Jamie Rossjohn; Jose A Villadangos
Journal:  Nat Immunol       Date:  2016-04-04       Impact factor: 25.606

2.  Keratin mediates the recognition of apoptotic and necrotic cells through dendritic cell receptor DEC205/CD205.

Authors:  Longxing Cao; Haishuang Chang; Xiangyi Shi; Chao Peng; Yongning He
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

3.  Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.

Authors:  Julia Rühl; Carmen Citterio; Christine Engelmann; Tracey Haigh; Andrzej Dzionek; Johannes Dreyer; Rajiv Khanna; Graham S Taylor; Joanna B Wilson; Carol S Leung; Christian Münz
Journal:  J Clin Invest       Date:  2019-04-15       Impact factor: 14.808

4.  Absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1.

Authors:  Lauren J Howson; Wael Awad; Anouk von Borstel; Hui Jing Lim; Hamish E G McWilliam; Maria L Sandoval-Romero; Shamik Majumdar; Abdul Rezzak Hamzeh; Thomas D Andrews; David H McDermott; Philip M Murphy; Jérôme Le Nours; Jeffrey Y W Mak; Ligong Liu; David P Fairlie; James McCluskey; Jose A Villadangos; Matthew C Cook; Stephen J Turner; Martin S Davey; Samar Ojaimi; Jamie Rossjohn
Journal:  Sci Immunol       Date:  2020-07-24

5.  Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists.

Authors:  Jennifer Connors; Bhavani Taramangalam; Gina Cusimano; Matthew R Bell; Stephanie M Matt; Kaitlyn Runner; Peter J Gaskill; Victor DeFilippis; Janko Nikolich-Žugich; Michele A Kutzler; Elias K Haddad
Journal:  Geroscience       Date:  2022-07-18       Impact factor: 7.581

6.  Quantifying Nanoparticle Internalization Using a High Throughput Internalization Assay.

Authors:  Sarah K Mann; Ewa Czuba; Laura I Selby; Georgina K Such; Angus P R Johnston
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.200

7.  Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza.

Authors:  Angita Shrestha; Jean-Remy Sadeyen; Deimante Lukosaityte; Pengxiang Chang; Adrian Smith; Marielle Van Hulten; Munir Iqbal
Journal:  NPJ Vaccines       Date:  2021-07-15       Impact factor: 7.344

Review 8.  Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines.

Authors:  Gunnveig Grødeland; Even Fossum; Bjarne Bogen
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

Review 9.  Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines.

Authors:  Cleo Goyvaerts; Karine Breckpot
Journal:  J Immunol Res       Date:  2015-10-25       Impact factor: 4.818

10.  Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles.

Authors:  Sheikh Tasnim Jahan; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.